verapamil has been researched along with phencyclidine in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (42.86) | 18.7374 |
1990's | 4 (19.05) | 18.2507 |
2000's | 6 (28.57) | 29.6817 |
2010's | 2 (9.52) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
Dansette, PM; Fontana, E; Poli, SM | 1 |
Abraham, MH; Acree, WE; Ibrahim, A | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Holopainen, I; Janáky, R; Oja, SS; Saransaari, P; Varga, V | 1 |
Benedetti, M; Pezzola, A; Popoli, P; Scotti de Carolis, A | 1 |
DeCoursey, TE; Jacobs, ER | 1 |
Browne, RG; Kozlowski, MR; Vinick, FJ | 1 |
McCann, DJ; Rabin, RA; Winter, JC | 1 |
Giannini, AJ; Krishen, A; Price, WA | 1 |
Bolger, GT; Crawley, JN; Paul, SM; Rafferty, MF; Skolnick, P | 1 |
McCann, DJ; Winter, JC | 1 |
McCann, DJ; Smith, CM; Winter, JC | 1 |
Montgomery, PT; Mueller, ME | 1 |
Altura, BM; Altura, BT | 1 |
Pert, CB; Quirion, R | 1 |
Buck, MG; Goswami, S; Maayani, S; Marom, Z; Rienzi, N; Schachter, EN; Zuskin, E | 1 |
1 review(s) available for verapamil and phencyclidine
Article | Year |
---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
20 other study(ies) available for verapamil and phencyclidine
Article | Year |
---|---|
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Effect of magnesium on calcium influx activated by glutamate and its agonists in cultured cerebellar granule cells.
Topics: 2-Amino-5-phosphonovalerate; Animals; Calcium; Calcium Radioisotopes; Cells, Cultured; Cerebellum; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Kainic Acid; Magnesium; N-Methylaspartate; Nifedipine; Phencyclidine; Quisqualic Acid; Rats; Rats, Wistar; Receptors, Glutamate; Verapamil | 1992 |
Verapamil and flunarizine inhibit phencyclidine-induced effects: an EEG and behavioural study in rats.
Topics: Animals; Behavior, Animal; Electroencephalography; Flunarizine; Injections, Intraventricular; Male; Nimodipine; Phencyclidine; Rats; Rats, Wistar; Verapamil | 1992 |
Mechanisms of potassium channel block in rat alveolar epithelial cells.
Topics: Animals; Calcium; Calcium Channels; Capsaicin; Cells, Cultured; Charybdotoxin; Chlorpromazine; Epithelium; Gallopamil; Kinetics; Nifedipine; Phencyclidine; Potassium Channels; Pulmonary Alveoli; Quinidine; Rats; Scorpion Venoms; Tacrine; Tetraethylammonium Compounds; Verapamil | 1990 |
Discriminative stimulus properties of phencyclidine (PCP)-related compounds: correlations with 3H-PCP binding potency measured autoradiographically.
Topics: Amantadine; Animals; Autoradiography; Conditioning, Operant; Hippocampus; Image Processing, Computer-Assisted; Male; Phencyclidine; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Phencyclidine; Reinforcement Schedule; Verapamil | 1986 |
Use of the radial maze in studies of phencyclidine and other drugs of abuse.
Topics: Animals; Brain; Learning; Lysergic Acid Diethylamide; Memory; Organ Specificity; Phenazocine; Phencyclidine; Scopolamine; Substance-Related Disorders; Verapamil | 1987 |
Management of acute PCP intoxication with verapamil.
Topics: Adult; Humans; Male; Phencyclidine; Psychoses, Substance-Induced; Verapamil | 1986 |
Effects of calcium antagonists on phencyclidine behaviors.
Topics: Animals; Calcium Channel Blockers; Dihydropyridines; Drug Interactions; Male; Mice; Motor Activity; Motor Skills; Nifedipine; Phencyclidine; Prazosin; Pyridines; Verapamil | 1986 |
Effects of phencyclidine, N-allyl-N-normetazocine (SKF-10,047), and verapamil on performance in a radial maze.
Topics: Animals; Conditioning, Psychological; Dose-Response Relationship, Drug; Male; Memory; Phenazocine; Phencyclidine; Rats; Rats, Inbred F344; Time Factors; Verapamil | 1986 |
A caution against use of verapamil in phencyclidine intoxication.
Topics: Animals; Dogs; Drug Synergism; Humans; Phencyclidine; Phencyclidine Abuse; Rats; Verapamil | 1986 |
Treatment of PCP intoxication with verapamil.
Topics: Adult; Akathisia, Drug-Induced; Confusion; Humans; Infusions, Parenteral; Male; Phencyclidine; Phencyclidine Abuse; Psychomotor Agitation; Verapamil | 1985 |
Pharmacologic inhibition of cerebral vasospasm in ischemia, hallucinogen ingestion, and hypomagnesemia: barbiturates, calcium antagonists, and magnesium.
Topics: Animals; Barbiturates; Brain Ischemia; Calcium Channel Blockers; Cerebral Arteries; Magnesium; Metabolic Diseases; Microcirculation; Nicotinic Acids; Nifedipine; Nimodipine; Nisoldipine; Phencyclidine; Rats; Verapamil; Water Supply | 1983 |
Certain calcium antagonists are potent displacers of [3H]phencyclidine (PCP) binding in rat brain.
Topics: Animals; Binding, Competitive; Brain; Calcium Channel Blockers; Gallopamil; In Vitro Techniques; Nifedipine; Nitrendipine; Olfactory Bulb; Phencyclidine; Rats; Verapamil | 1982 |
Pharmacologic characterization of wool dust extract in isolated guinea pig trachea.
Topics: Air Pollutants, Occupational; Animals; Atropine; Bronchoconstriction; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Dust; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Indomethacin; Leukotriene Antagonists; Male; Occupational Exposure; Pyrilamine; Trachea; Verapamil; Wool | 1995 |